In a previous study, Uysal et al. classified patients with COPD by the severity of symptoms and risk of exacerbation, and they found that elevated plasma levels of MMP-9, TIMP-1, and TIMP-2 correlated with the severity of disease. The gene discussed is MMP9; the disease is chronic obstructive pulmonary disease.